FWM
CLVS

Focused Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Focused Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$45K – 737
2018
Q2 		$45K Hold
1,000
– – 0.02% 287
2018
Q1 		$53K Sell
1,000
-15
-1% -$875 0.02% 294
2017
Q4 		$69K Sell
1,015
-85
-8% -$5.94K 0.02% 265
2017
Q3 		$91K Sell
1,100
-15
-1% -$1.19K 0.03% 169
2017
Q2 		$104K Sell
1,115
-1,100
-50% -$67.3K 0.04% 219
2017
Q1 		$141K Hold
2,215
– – 0.06% 185
2016
Q4 		$98K Sell
2,215
-2,650
-54% -$93.3K 0.04% 216
2016
Q3 		$175K Hold
4,865
– – 0.08% 155
2016
Q2 		$67K Buy
4,865
+2,189
+82% +$32K 0.03% 238
2016
Q1 		$51K Buy
2,676
+140
+6% +$2.96K 0.03% 192
2015
Q4 		$89K Buy
2,536
+1,293
+104% +$83.4K 0.05% 160
2015
Q3 		$114K Buy
1,243
+93
+8% +$8.05K 0.07% 132
2015
Q2 		$101K Buy
+1,150
New +$98.4K 0.06% 138

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return